Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as a 0.1% w/v ophthalmic suspension for ocular use. It treats postoperative ocular inflammation, uveitis, allergic conjunctivitis and ocular edema, providing anti‑inflammatory and immunosuppressive management of inflammatory eye conditions.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company emphasizes quality assurance and regulatory compliance in all markets.

Maxidex (dexamethasone) is a corticosteroid used to control ocular inflammation. - Postoperative ocular inflammation: reduces swelling, pain and cellular infiltrate following ocular surgery. - Uveitis: suppresses intra‑ocular inflammation to preserve vision and prevent tissue damage. - Allergic conjunctivitis: alleviates redness, itching and edema caused by allergic reactions in the eye. - Ocular edema: decreases fluid accumulation in ocular tissues associated with inflammatory processes.

Adverse ocular and systemic reactions may occur with Maxidex, although many patients experience no significant effects.

Common Side Effects: - Transient eye irritation or burning sensation. - Blurred vision. - Mild increase in intra‑ocular pressure. - Conjunctival hyperemia.

Serious or Rare Side Effects: - Severe elevation of intra‑ocular pressure leading to glaucoma. - Cataract formation with prolonged use. - Secondary ocular infection or delayed wound healing.

Before prescribing Maxidex, clinicians should consider several safety and handling precautions. - Assess baseline intra‑ocular pressure: monitor for steroid‑induced pressure rise. - Use with caution in patients with glaucoma or a history of ocular hypertension. - Limit duration of therapy: prolonged use increases risk of cataract and pressure elevation. - Avoid use in active ocular infection unless combined with appropriate antimicrobial therapy. - Do not apply to compromised corneal epithelium without specialist advice. - Store at room temperature: keep in original container, protect from light and moisture.

Maxidex may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use with potent intra‑ocular pressure‑raising agents (e.g., prostaglandin analogues) can exacerbate glaucoma. - Systemic corticosteroids: additive immunosuppression may increase infection risk.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce tear production, worsening dryness. - Non‑steroidal anti‑inflammatory eye drops: potential for delayed wound healing. - Antiviral agents (e.g., ganciclovir): monitor for reduced efficacy in viral keratitis.